Adempas
Adempas is an originator product from MSD Merck Sharp & Dohme AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 1'273.75 to CHF 2'531.10 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- MSD Merck Sharp & Dohme AG
- ATC code
- C02KX05
- IT group
- 02.07.10 Einfache blutdrucksenkende Mittel
- Active substances
- Riociguatum
- Preparation type
- Originator product
- On the SL since
- 01/01/2014
- Last price change
- 01/12/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Filmtabl 0.5 mg | 42 Stk | CHF 1'156.12 | CHF 1'273.75 | 01/01/2014 | B | 7680629030010 |
| Filmtabl 1 mg | 42 Stk | CHF 1'156.12 | CHF 1'273.75 | 01/01/2014 | B | 7680629030034 |
| Filmtabl 1.5 mg | 42 Stk | CHF 1'156.12 | CHF 1'273.75 | 01/01/2014 | B | 7680629030058 |
| Filmtabl 1.5 mg | 84 Stk | CHF 2'312.23 | CHF 2'531.10 | 01/01/2014 | B | 7680629030065 |
| Filmtabl 2 mg | 42 Stk | CHF 1'156.12 | CHF 1'273.75 | 01/01/2014 | B | 7680629030072 |
| Filmtabl 2 mg | 84 Stk | CHF 2'312.23 | CHF 2'531.10 | 01/01/2014 | B | 7680629030089 |
| Filmtabl 2.5 mg | 42 Stk | CHF 1'156.12 | CHF 1'273.75 | 01/01/2014 | B | 7680629030096 |
| Filmtabl 2.5 mg | 84 Stk | CHF 2'312.23 | CHF 2'531.10 | 01/01/2014 | B | 7680629030102 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes im Rahmen der erstmaligen Indikationsstellung durch entsprechend qualifizierte Fachärzte für Pneumologie und Kardiologie zur Behandlung von Patienten mit inoperabler chronisch-thromboembolischer pulmonaler Hypertonie (CTEPH) oder von Patienten mit persistierender oder rezidivierender CTEPH nach operativer Behandlung zur Verbesserung der körperlichen Leistungsfähigkeit.
Zur Behandlung erwachsener Patienten mit pulmonaler arterieller Hypertonie (PAH) der WHO-Funktionsklasse II und III zur Verbesserung der körperlichen Leistungsfähigkeit.
FAQ
Is Adempas covered by Swiss health insurance?
Yes, but only under conditions. Adempas is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Adempas cost in Switzerland?
The public price is the maximum price set by the FOPH and for Adempas ranges from CHF 1'273.75 to CHF 2'531.10 per pack. The ex-factory price ranges from CHF 1'156.12 to CHF 2'312.23. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages